Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
Enanta Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 44.81M | 60.21M | 84.35M | 37.23M | 35.77M | 63.54M | 39.93M | 85.39M | 95.18M | 73.18M | 42.22M | 43.99M | 28.37M | 40.99M | 99.07M | 57.21M | 4.6M | 77.13M | 55.09M |
Short-Term Investments | 159.3M | 133.16M | 132.34M | 210.95M | 194.31M | 236.77M | 297.22M | 284.52M | 291.41M | 136.91M | 172.25M | 205.24M | 224.92M | 239.34M | 159.98M | 186.8M | 252.22M | 298.82M | 331.1M |
Long-Term Investments | 3.36M | n/a | n/a | n/a | 42.51M | 3.97M | n/a | n/a | 5.92M | 15.04M | 26.94M | 29.29M | 39.43M | 42.22M | 88.67M | 108.42M | 115.71M | 24.49M | 18.46M |
Other Long-Term Assets | 94K | 3.46M | 3.45M | 3.45M | 3.46M | 187K | 4.73M | 4.77M | 4.8M | 4.66M | 4.67M | 4.66M | 4.67M | 700K | 700K | -1.37M | 700K | 700K | 700K |
Receivables | 8.36M | 40.63M | 40.16M | 38.65M | 40.63M | 39.79M | 39.91M | 39.62M | 44.81M | 46.57M | 51.29M | 49.04M | 48.21M | 47.46M | 56.4M | 60.83M | 52.19M | 20.13M | 31.74M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.24M | 8.86M | 11.29M | 13.02M | 15.87M | 10.93M | 13.24M | 13.26M | 17.07M | 14.48M | 17.95M | n/a | n/a | n/a | n/a | n/a | n/a | 32.14M | 28M |
Total Current Assets | 222.71M | 242.86M | 268.14M | 299.85M | 286.58M | 351.03M | 390.3M | 422.79M | 448.46M | 271.14M | 283.7M | 311.71M | 313.04M | 341.87M | 326.96M | 319.02M | 321.15M | 428.22M | 445.94M |
Property-Plant & Equipment | 74.87M | 76.67M | 77.04M | 73.35M | 66.26M | 58.37M | 33.46M | 34.71M | 35.98M | 35.6M | 32.22M | 29.75M | 28.08M | 22.03M | 24.27M | 10.65M | 12.53M | 14.01M | 15.56M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.18M | n/a | n/a | n/a | -2.07M | n/a | n/a | n/a |
Total Long-Term Assets | 78.32M | 80.13M | 80.5M | 76.8M | 112.24M | 62.53M | 38.2M | 39.48M | 46.7M | 55.31M | 63.83M | 63.7M | 72.18M | 64.95M | 113.64M | 119.77M | 129.28M | 39.55M | 35.07M |
Total Assets | 301.03M | 322.99M | 348.64M | 376.65M | 398.82M | 413.56M | 428.5M | 462.27M | 495.17M | 326.44M | 347.53M | 375.41M | 385.21M | 406.82M | 440.59M | 438.79M | 450.44M | 467.77M | 481.01M |
Account Payables | 3.55M | 4.76M | 4.73M | 8M | 10.68M | 6.73M | 9.33M | 4.1M | 7.93M | 11.76M | 4.35M | 6M | 1.25M | 5.99M | 7.84M | 9.54M | 5.89M | 5.7M | 6.3M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 30.15M | 30.68M | 32.74M | 34.46M | 32.3M | 33.67M | 41.48M | 35.08M | n/a | 4.92M | 3.49M | n/a | 2.6M | 3.01M | 3.47M | n/a | 5.03M | 5.17M | 5.2M |
Other Current Liabilities | 10.85M | n/a | n/a | n/a | 8.04M | 7.66M | 2.33M | n/a | 36.69M | 5.84M | 9.08M | n/a | 11.74M | 15.77M | 20.69M | n/a | 8.3M | 7.98M | 4.11M |
Total Current Liabilities | 44.55M | 45.95M | 49.05M | 57.53M | 58.23M | 54.61M | 62.41M | 62.79M | 68.19M | 32.17M | 23M | 29.83M | 23.04M | 30.74M | 37.89M | 36.17M | 28.62M | 26.62M | 23.04M |
Long-Term Debt | 121.29M | 126.73M | 131.09M | 136.13M | 143.31M | 149.2M | 153.03M | 160.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 252K | 243K | 235K | 231K | 227K | 224K | 649K | 663K | 166.83M | 1.83M | 1.84M | 1.88M | 1.95M | 2.38M | 2.36M | 2.06M | 2.33M | 2.47M | 2.45M |
Total Long-Term Liabilities | 177.2M | 183.51M | 187.78M | 190.3M | 191.68M | 192.84M | 174.21M | 182.75M | 189.16M | 24.9M | 23.7M | 24.25M | 24.16M | 17.5M | 18.32M | 3.19M | 3.96M | 5.12M | 5.97M |
Total Liabilities | 221.75M | 229.46M | 236.83M | 247.84M | 249.91M | 247.44M | 236.62M | 245.54M | 257.35M | 57.07M | 46.7M | 54.08M | 47.19M | 48.23M | 56.21M | 39.36M | 32.59M | 31.73M | 29.02M |
Total Debt | 207.1M | 216.14M | 221.29M | 226.06M | 226.17M | 229.86M | 25.49M | 26.51M | 27.7M | 28M | 25.34M | 25.26M | 24.81M | 18.13M | 19.43M | 5.33M | 6.67M | 7.82M | 8.72M |
Common Stock | n/a | 214K | 213K | 212K | 212K | 212K | 212K | 211K | 210K | 210K | 209K | 208K | 207K | 206K | 205K | 202K | 202K | 202K | 201K |
Retained Earnings | n/a | -367.97M | -345.33M | -323.04M | -294.22M | -271.56M | -240.4M | -207M | -178.89M | -139.82M | -102.17M | -73.18M | -46.83M | -15.13M | 18.46M | 48.58M | 73.17M | 97.2M | 119.24M |
Comprehensive Income | n/a | -224K | -29K | 302K | -653K | -667K | -534K | -1.17M | -1.5M | -1.81M | -2.67M | -3.72M | -3.62M | -3.04M | -1.01M | -382K | -264K | 55K | 405K |
Shareholders Equity | 79.28M | 93.54M | 111.82M | 128.81M | 148.91M | 166.11M | 191.88M | 216.74M | 237.82M | 269.38M | 300.84M | 321.33M | 338.02M | 358.58M | 384.38M | 399.43M | 417.85M | 436.03M | 452M |
Total Investments | 162.66M | 133.16M | 132.34M | 210.95M | 236.82M | 240.74M | 297.22M | 284.52M | 297.33M | 151.95M | 199.19M | 234.52M | 264.35M | 281.56M | 248.65M | 295.21M | 367.93M | 323.31M | 349.56M |